Wound healing compositions comprising biocompatible cellulose hydrogel membranes and methods of use thereof
The present invention provides a wound healing composition comprising a biocompatible hydrogel membrane wherein the hydrogel membrane has one or more of the following properties: high water content, high transparency, high permeability, high biocompatibility, high tensile strength and an optimal thickness. The invention further provides methods of treating a wound in a subject in need thereof, comprising contacting the wound with a biocompatible cellulose hydrogel membrane of the invention.
1. A method of treating a wound in a subject in need thereof, said method comprising contacting the wound with an effective amount of a re-wet biocompatible cellulose hydrogel membrane, wherein
the re-wet cellulose hydrogel membrane comprises one or more properties selected from the group consisting of: a cellulose content of from about 2% to about 9% by weight; a tensile strength of from about 50 kPa to about 600 kPa; a tear strength of from about 0.10 N/mm to about 0.60 N/mm; a strain to failure of from about 40% to about 80%; a suture retention strength of from about 0.05 N/mm to about 0.30 N/mm; a transparency that exceeds 85% at 550 nm (at 100 microns thickness); a Young's modulus of from about 100 kPa to about 700 kPa; and a puncture resistance of from about 50 kPa to about 300 kPa,
the re-wet biocompatible cellulose hydrogel membrane comprises a composite comprising microcrystalline cellulose and bacterial cellulose,
the re-wet biocompatible cellulose hydrogel membrane further comprises one or more microcrystalline cellulose layers and one or more bacterial cellulose layers,
the one or more bacterial cellulose layers are oriented closer to the wound than the one or more microcrystalline cellulose layers, and
the hydrogel membrane is in the shape of a contact lens.
2. The method of claim 1 , wherein the re-wet biocompatible cellulose hydrogel membrane further comprises a bioactive agent located on or within the membrane.
3. The method of claim 2 , wherein the bioactive agent is selected from the group consisting of proteins, peptides, carbohydrates, lipids, nucleic acids and fragments thereof, anti-viral compounds, anti-inflammatory compounds, antibiotic compounds such as antifungal and antibacterial compounds, cell differentiating agents, analgesics, contrast agents for medical diagnostic imaging, enzymes, cytokines, anaesthetics, antihistamines, agents that act on the immune system, hemostatic agents, hormones, angiogenic or anti-angiogenic agents, neurotransmitters, therapeutic oligonucleotides, viral particles, vectors, growth factors, retinoids, cell adhesion factors, extracellular matrix glycoproteins (such as laminin), osteogenic factors, antibodies and antigens.
4. The method of claim 1 , wherein the wound is an ocular wound and the re-wet biocompatible cellulose hydrogel membrane is in the shape of a contact lens.
5. The method of claim 4 , wherein the ocular wound is selected from the group consisting of non-penetrating injuries to the cornea and penetrating corneal injuries.
6. The method of claim 4 , wherein the re-wet biocompatible cellulose hydrogel membrane has a thickness from about 50 microns to about 200 microns.
7. The method of claim 2 , wherein the bioactive agent is encapsulated in the re-wet biocompatible cellulose hydrogel membrane with an encapsulating agent.
8. The method of claim 7 , wherein the bioactive agent exhibits controlled release from the re-wet biocompatible cellulose hydrogel membrane.
9. The method of claim 7 , wherein the bioactive agent is contained within nano- or microparticles within the re-wet biocompatible cellulose hydrogel membrane.
10. The method of claim 1 , wherein the re-wet biocompatible cellulose hydrogel membrane supports the growth of cells on or within the membrane.
11. The method of claim 10 , wherein the cells are selected from the group consisting of stem cells, progenitor cells, precursor cells, connective tissue cells, epithelial cells, muscle cells, neuronal cells, endothelial cells, fibroblasts, keratinocytes, smooth muscle cells, stromal cells, mesenchymal cells, immune system cells, hematopoietic cells, dendritic cells, hair follicle cells and combinations thereof.
12. The method of claim 11 , wherein the cells are able to grow on top of the re-wet biocompatible cellulose hydrogel membrane in a layered fashion or migrate within the re-wet biocompatible cellulose hydrogel membrane.
13. The method of claim 1 , wherein the re-wet biocompatible cellulose hydrogel membrane comprises one or more cellulose fiber layers.
14. The method of claim 1 , wherein the transparency of the re-wet biocompatible cellulose hydrogel membrane exceeds 90% at 550 nm for a 100 micron thick gel.
15. The method of claim 14 , wherein the transparency of the re-wet biocompatible cellulose hydrogel membrane exceeds 95% at 550 nm for a 100 micron thick gel.
16. The method of claim 1 , wherein the cellulose is functionalized with one or more amine groups.
17. The method of claim 1 , wherein the re-wet biocompatible cellulose hydrogel membrane further comprises one more synthetic or natural polymers.
18. The method of claim 17 , wherein the re-wet biocompatible cellulose hydrogel membrane has a shape selected from the group consisting of a contact lens and a shape configured to match the shape of a wound.
19. The method of claim 1 , wherein the re-wet biocompatible cellulose hydrogel membrane is a composite comprising microcrystalline cellulose and bacterial cellulose.